Capstone Investment Advisors »

Apellis Pharmaceuticals shares owned by Capstone Investment Advisors

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Capstone Investment Advisors from 13F filings

Historical chart of Capstone Investment Advisors investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Capstone Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $10M 250k 40.23
2025-09-30 $484k 21k 22.63
2025-06-30 $203k 12k 17.31
2021-03-31 $1.3M 31k 42.92
2020-12-31 $1.7M 31k 57.21

More positions owned by Capstone Investment Advisors

Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr China Lg-cap Etf (FXI)
Alphabet Cap Stk Cl A (GOOGL)
Lumentum Hldgs Note 1.500%12/1 (Principal)
Meta Platforms Cl A (META)
Select Sector Spdr Tr State Street Fin Call Option (XLF)
Western Digital Corp Note 3.000%11/1 (Principal)

View all positions for Capstone Investment Advisors

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals